134 related articles for article (PubMed ID: 15645679)
21. Virus inactivation in albumin by a combination of alkali conditions and high temperature.
Roberts PL; More J; Rott J; Lewin D
Biologicals; 2011 Mar; 39(2):67-72. PubMed ID: 21333548
[TBL] [Abstract][Full Text] [Related]
22. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence.
Kerr JR
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):335-9. PubMed ID: 16316396
[TBL] [Abstract][Full Text] [Related]
24. Validation of model virus removal and inactivation capacity of an erythropoietin purification process.
Pérez M; Rodríguez E; Rodríguez M; Paez R; Ruibal I; Noa E; García O; Moya G; Martínez M; Marcelo J; Martínez A; Dubal M; Navea L; Valdés R
Biologicals; 2011 Nov; 39(6):430-7. PubMed ID: 21982851
[TBL] [Abstract][Full Text] [Related]
25. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
26. Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction.
Alvarez-Lafuente R; Fernández-Gutiérrez B; Jover JA; Júdez E; Loza E; Clemente D; García-Asenjo JA; Lamas JR
Ann Rheum Dis; 2005 May; 64(5):780-2. PubMed ID: 15834059
[TBL] [Abstract][Full Text] [Related]
27. Dry-heat sensitivity of human B19 and porcine parvoviruses.
Prikhod'ko GG
Transfusion; 2005 Oct; 45(10):1692-3. PubMed ID: 16181226
[No Abstract] [Full Text] [Related]
28. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
29. Effects of probe binding mutations in an assay designed to detect parvovirus B19: implications for the quantitation of different virus genotypes.
Baylis SA; Fryer JF; Grabarczyk P
J Virol Methods; 2007 Jan; 139(1):97-9. PubMed ID: 17045660
[TBL] [Abstract][Full Text] [Related]
30. Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles.
Gilbert L; Toivola J; White D; Ihalainen T; Smith W; Lindholm L; Vuento M; Oker-Blom C
Biochem Biophys Res Commun; 2005 Jun; 331(2):527-35. PubMed ID: 15850791
[TBL] [Abstract][Full Text] [Related]
31. Parvovirus B19 infection in children with acute illness and rash.
Pruksachatkunakorn C; Apichartpiyakul N; Kanjanaratanakorn K
Pediatr Dermatol; 2006; 23(3):216-8. PubMed ID: 16780465
[TBL] [Abstract][Full Text] [Related]
32. Detection of the human Parvovirus B19 in nonimmune hydrops fetalis using immunohistochemistry and nested-PCR in formalin-fixed and paraffin-embedded placenta and fetal tissues.
Landolsi H; Yacoubi MT; Bouslama L; Lahmar A; Trabelsi A; Hmissa S; Aouni M; Korbi S
Pathol Biol (Paris); 2009 May; 57(3):e1-7. PubMed ID: 18243574
[TBL] [Abstract][Full Text] [Related]
33. Virus inactivation of plasma-derived proteins by pasteurization in the presence of guanidine hydrochloride.
Schlegel A; Immelmann A; Kempf C
Transfusion; 2001 Mar; 41(3):382-9. PubMed ID: 11274595
[TBL] [Abstract][Full Text] [Related]
34. Infection and temporal arteritis: a PCR-based study to detect pathogens in temporal artery biopsy specimens.
Cooper RJ; D'Arcy S; Kirby M; Al-Buhtori M; Rahman MJ; Proctor L; Bonshek RE
J Med Virol; 2008 Mar; 80(3):501-5. PubMed ID: 18205226
[TBL] [Abstract][Full Text] [Related]
35. Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19.
Caillet-Fauquet P; Di Giambattista M; Draps ML; Sandras F; Branckaert T; de Launoit Y; Laub R
J Virol Methods; 2004 Jun; 118(2):131-9. PubMed ID: 15081608
[TBL] [Abstract][Full Text] [Related]
36. Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection.
Navalpotro D; Gimeno C; Navarro D
J Med Virol; 2006 Nov; 78(11):1449-51. PubMed ID: 16998885
[TBL] [Abstract][Full Text] [Related]
37. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman.
Bonvicini F; Marinacci G; Pajno MC; Gallinella G; Musiani M; Zerbini M
Clin Infect Dis; 2008 Aug; 47(3):385-7. PubMed ID: 18558883
[TBL] [Abstract][Full Text] [Related]
38. Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb).
Azari M; Boose JA; Burhop KE; Camacho T; Catarello J; Darling A; Ebeling AA; Estep TN; Pearson L; Guzder S; Herren J; Ogle K; Paine J; Rohn K; Sarajari R; Sun CS; Zhang L
Biologicals; 2000 Jun; 28(2):81-94. PubMed ID: 10885615
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens.
Bonvicini F; Manaresi E; Gallinella G; Gentilomi GA; Musiani M; Zerbini M
BJOG; 2009 May; 116(6):813-7. PubMed ID: 19432570
[TBL] [Abstract][Full Text] [Related]
40. Correlates of placental infection with cytomegalovirus, parvovirus B19 or human herpes virus 7.
Chow SS; Craig ME; Jacques CF; Hall B; Catteau J; Munro SC; Scott GM; Camaris C; McIver CJ; Rawlinson WD
J Med Virol; 2006 Jun; 78(6):747-56. PubMed ID: 16628574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
